ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01454622
Brief Title: A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers

First Submitted : October 17, 2011
First Submitted that Met QC Criteria : October 17, 2011
First Posted : October 19, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : May 3, 2013
Last Update Posted : May 6, 2013 (Estimate)